On the Record · Qiagen
Qiagen acquisitions, on the record
The businesses Qiagen bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
Verogen, Inc.Word for word“Investing activities during 2023 consisted principally of $1.0 billion for purchases of short-term investments, $149.7 million in cash paid for purchases of property and equipment, $149.5 million of net cash paid for the acquisition of Verogen, Inc., $66.6 million paid to our derivative counterparties to collateralize our derivative liabilities with them as discussed in Note 14 "Derivatives and Hedging," and $13.1 million paid for intangible assets.” 20-F for 2023 | acquisition | — | $149.5 million of net cash paid for the acquisition of Verogen, Inc. |
BLIRT S.A.Word for word“Cash used in investing activities during 2022 consisted principally of $1.4 billion for purchases of short-term investments, $129.2 million for purchases of property, plant and equipment, $63.7 million of net cash paid for the acquisition of BLIRT S.A., $20.1 million paid for intangible assets and $9.9 million returned to us from our derivative counterparties with cash provided to them to collateralize our derivative liabilities with them.” 20-F for 2023 | acquisition | — | $63.7 million of net cash paid for the acquisition of BLIRT S.A. |
Parse Biosciences, Inc.Word for word“In December 2025, we acquired Parse Biosciences, Inc. a privately held, leading provider of scalable, instrument-free solutions for single-cell research located in Seattle, Washington.” 20-F for 2025 | acquisition | December 2025 | — |
GNX Data Systems Ltd. (doing business as Genoox)Word for word“In May 2025, we acquired GNX Data Systems Ltd. (doing business as Genoox).” 20-F for 2025 | acquisition | May 2025 | — |
| Fiscal year ended | Cash paid for acquisitions (net of cash acquired) | Cash received from selling businesses | Goodwill from acquisitions |
|---|---|---|---|
| 2016-12-31 | $90.5 million | $0 | $76.8 million |
| 2017-12-31 | $50.5 million | $0 | $26.9 million |
| 2018-12-31 | $172.8 million | $16.4 million | $142.3 million |
| 2019-12-31 | $68.1 million | $1 million | $34.8 million |
| 2020-12-31 | $239.6 million | $1.8 million | $157.6 million |
| 2021-12-31 | $0 | $0 | $0 |
| 2022-12-31 | $63.7 million | $0 | $42.2 million |
| 2023-12-31 | $149.5 million | — | $95.1 million |
| 2024-12-31 | $0 | — | $0 |
| 2025-12-31 | $291.2 million | — | $187.9 million |
Read from Qiagen’s annual reports (20-F for 2025, 20-F for 2024, 20-F for 2023) and the financial data it files with the SEC, as of 2026-03-20. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.